Hydrogen suppressed tumor growth during chronic intermittent hypoxia via modulating macrophage polarization.
Qing-Qing Liu, Chen-Bing Zhao, Zhuo Wang, Mengfang Sun, Ke-Rong Qi, Han Liu, Qian Li, Yashuo Zhao, Ya-Jing Guo, En-Sheng Ji · Scientific reports · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In an animal model, these findings highlighted that hydrogen treatment suppressed tumor growth by modulating the tumor immune microenvironment and inhibiting angiogenesis. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen was evaluated in this publication and summarizes the source-grounded findings below. These findings highlighted that hydrogen treatment suppressed tumor growth by modulating the tumor immune microenvironment and inhibiting angiogenesis.
What the Researchers Studied
The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
To evaluate the therapeutic effects of hydrogen, both in vitro and in vivo models were established. in vitro studies revealed that hydrogen directly inhibited lung cancer cell survival and migration, and downregulated key components of the CCL2-CCR2 pathway, mirroring the effects observed with a CCR2 inhibitor. These findings highlighted that hydrogen treatment suppressed tumor growth by modulating the tumor immune microenvironment and inhibiting angiogenesis. The authors concluded that the results suggested that hydrogen may represented a novel and promising therapeutic strategy for lung cancer.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The study used a preclinical animal experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.